Earnings Summary

Genmab A/S’s revenue jumped 65.79% since last year same period to $1724Mn in the Q3 2020. On a quarterly growth basis, Genmab A/S has generated -68.37% fall in its revenue since last 3-months.

Genmab A/S’s net profit fell -1.31% since last year same period to $530Mn in the Q3 2020. On a quarterly growth basis, Genmab A/S has generated -84.31% fall in its net profits since last 3-months.

Genmab A/S’s net profit margin fell -40.48% since last year same period to 30.74% in the Q3 2020. On a quarterly growth basis, Genmab A/S has generated -50.39% fall in its net profit margins since last 3-months.

Genmab A/S’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -64.13% fall from last quarter’s estimates.

Genmab A/S’s earning per share (EPS) estimates for the current year stand at 0.13.

Genmab A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Genmab A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.